miércoles, 21 de agosto de 2024

FDA OKs First-Line Lazertinib With Amivantamab for NSCLC Megan Brooks August 20, 2024

https://www.medscape.com/viewarticle/fda-oks-first-line-lazertinib-amivantamab-nsclc-2024a1000faa

No hay comentarios:

Publicar un comentario